Struma ovarii other diagnostic studies

Struma ovarii Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Struma ovarii from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
ECG
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Struma ovarii other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Struma ovarii other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Struma ovarii other diagnostic studies
CDC on Struma ovarii other diagnostic studies
Struma ovarii other diagnostic studies in the news
Blogs on Struma ovarii other diagnostic studies
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Struma ovarii other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Radiological findings, ascites and raised CA-125 levels make it a unique and highly suspicious case of malignancy. Histopathologic studies may aid in diagnosing the malignant struma ovarii when there is no evidence of clinical malignancy or metastases.

Other Diagnostic Studies

Radiological findings, ascites and raised CA-125 levels make it a unique and highly suspicious case of malignancy. Histopathologic studies may aid in diagnosing the malignant struma ovarii when there is no evidence of clinical malignancy or metastases.